David Weingeist
Company: Johnson & Johnson Innovative Medicine
Job title: Director - Scientific & Oncology Diagnostics Leader
Seminars:
Revolutionizing Early Bladder Cancer Detection with Urine-Based Genomic Liquid Biopsies 1:40 pm
Utilizing urine samples for patient screening, providing a reliable and patient-friendly alternative that addresses the challenges associated with tissue and plasma-based testing Employing a highly sensitive genomic method capable of identifying a broad spectrum of genetic alterations Leveraging the robust detection capabilities of urine-based assays to facilitate earlier diagnosis and more personalized treatment strategiesRead more
day: Day Two Track A (PM)
Harnessing Multi-Analytes to Advance Comprehensive Oncology Understanding to Unlock Deeper Insights into Patient Surveillance
Chaired by: 10:50 am
day: Day Two Track A (AM)